Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease

The octapeptide long acting somatostatin analogue, SMS 201-995 promotes intestinal fluid and electrolyte absorption and inhibits anion secretion. It is more potent than native somatostatin and does not exhibit tachyphylaxsis. SMS 201-995 was used to treat two patients with severe diarrhea associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard N. Fedorak, Richard W. Sherbaniuk
Format: Article
Language:English
Published: Wiley 1989-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1989/525713
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560247032512512
author Richard N. Fedorak
Richard W. Sherbaniuk
author_facet Richard N. Fedorak
Richard W. Sherbaniuk
author_sort Richard N. Fedorak
collection DOAJ
description The octapeptide long acting somatostatin analogue, SMS 201-995 promotes intestinal fluid and electrolyte absorption and inhibits anion secretion. It is more potent than native somatostatin and does not exhibit tachyphylaxsis. SMS 201-995 was used to treat two patients with severe diarrhea associated with Crohn’s disease after other treatments had failed. The volume and frequency of ileostomy output in one patient and stool output in the other did not respond to therapy with SMS 201-995. ln fact, diarrhea appeared to increase in both patients while on treatment.
format Article
id doaj-art-5dc7093e9f25448fbbb4fd60ca358563
institution Kabale University
issn 0835-7900
language English
publishDate 1989-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-5dc7093e9f25448fbbb4fd60ca3585632025-02-03T01:28:01ZengWileyCanadian Journal of Gastroenterology0835-79001989-01-0132535710.1155/1989/525713Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel DiseaseRichard N. Fedorak0Richard W. Sherbaniuk1Department of Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaThe octapeptide long acting somatostatin analogue, SMS 201-995 promotes intestinal fluid and electrolyte absorption and inhibits anion secretion. It is more potent than native somatostatin and does not exhibit tachyphylaxsis. SMS 201-995 was used to treat two patients with severe diarrhea associated with Crohn’s disease after other treatments had failed. The volume and frequency of ileostomy output in one patient and stool output in the other did not respond to therapy with SMS 201-995. ln fact, diarrhea appeared to increase in both patients while on treatment.http://dx.doi.org/10.1155/1989/525713
spellingShingle Richard N. Fedorak
Richard W. Sherbaniuk
Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
Canadian Journal of Gastroenterology
title Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
title_full Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
title_fullStr Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
title_full_unstemmed Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
title_short Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
title_sort absence of effect of somatostatin analogue sms 201 995 in diarrhea associated with inflammatory bowel disease
url http://dx.doi.org/10.1155/1989/525713
work_keys_str_mv AT richardnfedorak absenceofeffectofsomatostatinanaloguesms201995indiarrheaassociatedwithinflammatoryboweldisease
AT richardwsherbaniuk absenceofeffectofsomatostatinanaloguesms201995indiarrheaassociatedwithinflammatoryboweldisease